PanTher Therapeutics Overview

  • Founded
  • 2014
Founded
  • Status
  • Private
  • Employees
  • 3
Employees
  • Latest Deal Type
  • Series A
  • Latest Deal Amount
  • $7.33M
Latest Deal Amount
  • Investors
  • 10

PanTher Therapeutics General Information

Description

Developer of proprietary treatment platform to enhance therapeutic response with minimal side effects. The company's adaptable platform empowers oncologists to treat patients with life-threatening cancer by unlocking a drug's full potential through direct, sustained treatment at the tumor site. This distinctive targeting capability uniquely positions PanTher to take on the deadliest and most difficult to treat cancers with a lead investigational candidate in pancreatic cancer.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Other Healthcare Technology Systems
Primary Office
  • C/O LabCentral
  • 700 Main Street
  • Cambridge, MA 02139
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

PanTher Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC (Series A) 19-May-2021 $7.33M 00.000 00.00 Completed Clinical Trials - Phase 1
6. Accelerator/Incubator 0000 Completed Pre-Clinical Trials
5. Accelerator/Incubator 04-Mar-2016 0000 Completed Startup
4. Accelerator/Incubator 02-Nov-2015 0000 Completed Startup
3. Angel (individual) 08-Jun-2015 0000 0000 Completed Startup
2. Accelerator/Incubator 07-May-2015 Completed Startup
1. Accelerator/Incubator 05-Jan-2015 Completed Startup
To view PanTher Therapeutics’s complete valuation and funding history, request access »

PanTher Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
To view PanTher Therapeutics’s complete cap table history, request access »

PanTher Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of proprietary treatment platform to enhance therapeutic response with minimal side effects. The company's ada
Drug Discovery
Cambridge, MA
3 As of 2021
00.000
0.00 0000-00-00
00000000000 00.000

00000000

aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Ex
0000 00000000
Raleigh, NC
0 As of 0000
00.00
0000000000 00.00

00000000

is nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dol
00000000 0000000
Westminster, CO
00 As of 0000
000.00
00000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

PanTher Therapeutics Competitors (3)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Advanced Chemotherapy Technologies Venture Capital-Backed Raleigh, NC 0 00.00 0000000000 00.00
00000000 0000 0000 Venture Capital-Backed Westminster, CO 00 000.00 00000000000 000.00
00000000 Formerly VC-backed Los Altos, CA 0 000.00 00000000 000.00
You’re viewing 3 of 3 competitors. Get the full list »

PanTher Therapeutics Executive Team (6)

Name Title Board Seat Contact Info
Laura Indolfi Ph.D Co-Founder, Chief Executive Officer, Board Member & President
David Ting MD Scientific Co-Founder & Board Member
Elazer Edelman Ph.D Scientific Co-Founder
David Mackey Strategic Advisor
J. Marc Pipas Chief Medical Officer
You’re viewing 5 of 6 executive team members. Get the full list »

PanTher Therapeutics Board Members (5)

Name Representing Role Since
Darshana Zaveri Self Business Advisor & Board Member 000 0000
David Ting MD PanTher Therapeutics Scientific Co-Founder & Board Member 000 0000
Laura Indolfi Ph.D PanTher Therapeutics Co-Founder, Chief Executive Officer, Board Member & President 000 0000
Manish Bhandari MD Angel Physicians Fund Board Member 000 0000
Maria Palasis Ph.D Self Board Member 000 0000
To view PanTher Therapeutics’s complete board members history, request access »

PanTher Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

PanTher Therapeutics Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Angel Physicians Fund Venture Capital Minority 000 0000 000000 0
Catalyst Health Ventures Venture Capital Minority 000 0000 000000 0
Kli Capital Venture Capital Minority 000 0000 000000 0
Mission BioCapital Venture Capital Minority 000 0000 000000 0
R42 Group Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 10 investors. Get the full list »